Foulk R

No ORCID on file · 2 papers in corpus · active 2014-2025
2025
F&S reports ·doi:10.1016/j.xfre.2025.07.003

ObjectiveTo evaluate the risk of ovarian hyperstimulation syndrome (OHSS) with highly purified human menopausal gonadotropin (HP-hMG) or recombinant follicle-stimulating hormone (rFSH) for controlled ovarian stimulation in patients predicte…

2014
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deu194

Study questionIs the ongoing pregnancy rate with a new aqueous formulation of subcutaneous progesterone (Prolutex(®)) non-inferior to vaginal progesterone (Endometrin(®)) when used for luteal phase support of in vitro fertilization?Summary …